Clinical characteristics of children who visited the emergency department with extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection and its risk factors
Pediatric Emergency Medicine Journal. 2020;7(2):101-107 
Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department
The American Journal of Emergency Medicine. 2018;36(9):1608-1612
C14.12 Risk factors for urinary tract infections due to extended-spectrum β-lactamase producing Escherichia coli in Children
International Journal of Antimicrobial Agents. 2005;26:S101
Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections
Antimicrobial Resistance and Infection Control. 2014;3(1):
Evaluation of ESBL (Extended Spectrum Beta-Lactamase) Producing Escherichia Coli Isolated from Patients with Urinary Tract Infection by Phenotypic and Genotypic Methods
. 2020;
Detection of CTX-M Gene in Escherichia coli Producing Extended Spectrum Beta Lactamase (ESBL) Isolated from Patients with Urinary Tract Infection
International Journal of Medical Science and Clinical Invention. 2021;8(09):5610-5614
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study
Clinical Microbiology and Infection. 2017;23(12):952-960
Ampicillin/gentamicin
Reactions Weekly. 2020;1814(1):38-38
Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing <em>Escherichia coli</em> in children
Infection and Drug Resistance. 2017;Volume 10:393-399
Service evaluation of selected risk factors for extended-spectrum beta-lactamase Escherichia coli urinary tract infections: a case–control study
Journal of Hospital Infection. 2014;88(2):116-119